MedTrace Logo

Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer

NCT02648919 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2021-11-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effects of Noni extract in men diagnosed with very low risk or low risk prostate cancer

Conditions

Interventions

DRUG

Noni extract

Intervention will be administered on an outpatient basis.Six bottles containing 60 capsules will be dispensed to all participants upon enrollment. Then 12 bottles (at 30-day visit) and 18 bottles (at 3, 6 and 9 month visits) will be dispensed to all participants.

Sponsors & Collaborators

  • University of Hawaii Cancer Research Center

    collaborator OTHER

  • University of Hawaii

    lead OTHER

Principal Investigators

  • Jeffrey Huang, PharmD · Faculty

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02648919 on ClinicalTrials.gov